Skip to Main Content

Paper Details

Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial.
AIDS Behav
23
2019
CD4, HIV, HIV-Positive, HIV-positive, NTX, Naltrexone, Patients, alcohol, naltrexone, participants, patients
Author NameAffiliation
Tassos C KyriakidesYale Center for Analytic Sciences, Yale University School of Public Health, Yale University
Sheldon T BrownJames J. Peters VA Medical Center
Amy C JusticeYale School of Medicine, Yale University
Amy C JusticeVA Connecticut Healthcare System
Kendall BryantNational Institute on Alcohol Abuse and Alcoholism
David A FiellinYale School of Medicine, Yale University
David A FiellinCenter for Interdisciplinary Research on AIDS, Yale School of Public Health
  • 1 - 7

Datasets

Release 1.2